Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without immunosuppression. The company's engineered cell product (UP421 ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell ...

Clinical islet transplantation is gaining acceptance as a potential therapy, particularly for subjects who have labile diabetes or problems with hypoglycemic awareness. The risks of the procedure ...

Transplanting insulin-producing cells along with engineered blood ... “This work lays the foundation for subcutaneous [under the skin] islet transplants as a relatively safe and durable ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine ...

Islet transplantation is a procedure in which insulin-producing cell clusters (islets) are purified from a deceased organ ...

POSTECH researchers develop 3D printed platform to enhance diabetes treatment POSTECH scientists create advanced 3D printing ...

Researchers have developed a method using engineered blood vessel cells (R-VECs) to improve islet transplantation which could offer a safer and more effective treatment for type 1 diabetes. In a study ...